Milestone Pharmaceuticals Inc. (MIST) NASDAQ

Currency In USD

Milestone Pharmaceuticals Inc.

Address

1111 Dr. Frederik-Philips Boulevard

Montreal, QC H4M 2X6

Canada

Phone

15143360444

Website

https://www.milestonepharma.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

May 09, 2019

Key Executives

Name	Title	Pay	Year Born
Joseph G. Oliveto	Chief Executive Officer, President & Director	931,384	1968
Lorenz Muller	Chief Commercial Officer	397,534	1964
Amit Hasija	Chief Financial Officer & Executive Vice President of Corporate Development	631,860	1973
David Bharucha FACC	Chief Medical Officer	664,417	1962
Philippe Douville	Founder, Strategic Advisor & Member of Scientific Advisory Board	0	1962
Guy Rousseau	SVP of Regulatory Affairs and Quality Management	0	N/A
Philip T. Sager FACC FAHA FHRS	Chief Medical Advisor & Member of the Scientific Advisory Board	0	1956
Jeff Moore	Vice President of Sales	0	N/A
Jeff Nelson	Chief Operating Officer	0	1981
Roshan Girglani	Vice President of Marketing	0	N/A
Anita Holz	Vice President & Head of Medical Affairs	0	N/A
David Sandoval	General Counsel & Chief Compliance Officer	0	1978

Description

Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.